User profiles for Patrick Giguère

Patrick Giguere

Associate Professor at University of Ottawa
Verified email at uottawa.ca
Cited by 4390

Structure-based discovery of opioid analgesics with reduced side effects

…, H Hübner, XP Huang, MF Sassano, PM Giguère… - Nature, 2016 - nature.com
Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side
effects of morphine and related opioids—which include fatal respiratory depression—are …

PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome

…, K Lansu, JD McCorvy, PM Giguère… - Nature structural & …, 2015 - nature.com
G protein–coupled receptors (GPCRs) are essential mediators of cellular signaling and are
important targets of drug action. Of the approximately 350 nonolfactory human GPCRs, more …

Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets

AJ Kimple, DE Bosch, PM Giguère… - Pharmacological reviews, 2011 - ASPET
Because G-protein coupled receptors (GPCRs) continue to represent excellent targets for
the discovery and development of small-molecule therapeutics, it is posited that additional …

Molecular control of δ-opioid receptor signalling

G Fenalti, PM Giguere, V Katritch, XP Huang… - Nature, 2014 - nature.com
Opioids represent widely prescribed and abused medications, although their signal transduction
mechanisms are not well understood. Here we present the 1.8 Å high-resolution crystal …

[PDF][PDF] A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior

…, C Li, RHJ Olsen, JF DiBerto, PM Giguere… - Neuron, 2015 - cell.com
DREADDs are chemogenetic tools widely used to remotely control cellular signaling, neuronal
activity, and behavior. Here we used a structure-based approach to develop a new G i -…

[HTML][HTML] Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform

…, G Laroche, JD Freitas, R Wang, PM Giguère - Nature …, 2023 - nature.com
Representing the most attractive and successful druggable receptors of the proteome, GPCRs
regulate a myriad of physiological and pathophysiological functions. Although over half of …

[PDF][PDF] The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy

…, KW Wen, B Damania, CB Moore, PM Giguère… - Immunity, 2012 - cell.com
The mitochondrial protein MAVS (also known as IPS-1, VISA, and CARDIF) interacts with
RIG-I-like receptors (RLRs) to induce type I interferon (IFN-I). NLRX1 is a mitochondrial …

[HTML][HTML] Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2

…, SAL Bennett, AM Crawley, PM Giguère… - …, 2021 - thelancet.com
Background Antibodies raised against human seasonal coronaviruses (sCoVs), which are
responsible for the common cold, are known to cross-react with SARS-CoV-2 antigens. This …

Structural basis for bifunctional peptide recognition at human δ-opioid receptor

G Fenalti, NA Zatsepin, C Betti, P Giguere… - Nature structural & …, 2015 - nature.com
Bifunctional μ- and δ-opioid receptor (OR) ligands are potential therapeutic alternatives, with
diminished side effects, to alkaloid opiate analgesics. We solved the structure of human δ-…

[HTML][HTML] Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models

…, S Beitari, K Matte, G Laroche, PM Giguère… - Communications …, 2022 - nature.com
Nanobodies offer several potential advantages over mAbs for the control of SARS-CoV-2.
Their ability to access cryptic epitopes conserved across SARS-CoV-2 variants of concern (…